BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16197447)

  • 1. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults.
    Shaw GR
    Br J Haematol; 2005 Oct; 131(2):180-4. PubMed ID: 16197447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.
    Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM
    Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Remacha AF; Nomdedéu JF; Puget G; Estivill C; Sarda MP; Canals C; Aventin A
    Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease in older adults.
    Bain B
    Br J Haematol; 2006 Aug; 134(3):340; author reply 340-1. PubMed ID: 16787502
    [No Abstract]   [Full Text] [Related]  

  • 5. [Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies].
    Gérard J; Dubois-Galopin F; Gardembas-Pain M; Defaux JB; Schmidt-Tanguy A; Godon A; Geneviève F; Blanchet O; Ifrah N; Zandecki M
    Ann Biol Clin (Paris); 2005; 63(6):653-9. PubMed ID: 16330386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome.
    Gupta R; Abdalla SH; Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):615-9. PubMed ID: 10492088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals.
    Cabello AI; Collado R; Ruiz MA; Martínez J; Navarro I; Ferrer R; Sosa AM; Carbonell F
    Leuk Res; 2005 Apr; 29(4):365-70. PubMed ID: 15725469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
    Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
    Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
    Atallah E; Nussenzveig R; Yin CC; Bueso-Ramos C; Tam C; Manshouri T; Pierce S; Kantarjian H; Verstovsek S
    Leukemia; 2008 Jun; 22(6):1295-8. PubMed ID: 18059483
    [No Abstract]   [Full Text] [Related]  

  • 11. Sideroblastic anaemia with reactive thrombocytosis versus myelodysplastic/myeloproliferative disease.
    Pérez Sánchez I; Pérez Corrala A; Menarguez Palanca J; Mayayo Crespo M; Escudero Soto A; Pintado Cros T
    Leuk Lymphoma; 2003 Mar; 44(3):557-9. PubMed ID: 12688334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2017 Mar; 92(3):297-310. PubMed ID: 28188970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myelodysplastic syndrome classification].
    Ghariani I; Braham N; Hassine M; Kortas M
    Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
    Broseus J; Florensa L; Zipperer E; Schnittger S; Malcovati L; Richebourg S; Lippert E; Cermak J; Evans J; Mounier M; Raya JM; Bailly F; Gattermann N; Haferlach T; Garand R; Allou K; Besses C; Germing U; Haferlach C; Travaglino E; Luno E; Pinan MA; Arenillas L; Rozman M; Perez Sirvent ML; Favre B; Guy J; Alonso E; Ahwij N; Jerez A; Hermouet S; Maynadié M; Cazzola M; Girodon F
    Haematologica; 2012 Jul; 97(7):1036-41. PubMed ID: 22532522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T) with superimposed 5q-syndrome.
    Ziarkiewicz M; Dwilewicz-Trojaczek J; Pastwińska A; Chmarzyńska E; Paszkowska-Kowalewska M; Koperski Ł; Jędrzejczak WW; Ziarkiewicz-Wróblewska B
    Pol J Pathol; 2010; 61(2):105-9. PubMed ID: 20924996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
    Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
    Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Schmitt-Graeff AH; Teo SS; Olschewski M; Schaub F; Haxelmans S; Kirn A; Reinecke P; Germing U; Skoda RC
    Haematologica; 2008 Jan; 93(1):34-40. PubMed ID: 18166783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
    Dewulf G; Gouin I; Pautas E; Gaussem P; Chaïbi P; Andreux JP; Siguret V
    Ann Biol Clin (Paris); 2004; 62(2):197-202. PubMed ID: 15047472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.